{"id":4051,"date":"2023-03-28T15:46:03","date_gmt":"2023-03-28T19:46:03","guid":{"rendered":"https:\/\/icam-cimu.ca\/?post_type=sessions&p=4051"},"modified":"2023-03-28T15:46:03","modified_gmt":"2023-03-28T19:46:03","slug":"hr-p-2-correlation-of-clinical-features-to-dna-methylation-based-prognostic-subtypes-in-chorodoma-patients","status":"publish","type":"sessions","link":"https:\/\/icam-cimu.ca\/fr\/sessions\/hr-p-2-correlation-of-clinical-features-to-dna-methylation-based-prognostic-subtypes-in-chorodoma-patients\/","title":{"rendered":"HR-P-2 | Correlation Of Clinical Features To DNA Methylation Based Prognostic Subtypes In Chorodoma Patients"},"template":"","accreditation":[60],"speakers":[],"session-themes":[37],"sessions":[32],"class_list":["post-4051","sessions","type-sessions","status-publish","hentry","accreditation-non-accredited","session-themes-health-research","sessions-poster-sessions"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions\/4051"}],"collection":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions"}],"about":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/types\/sessions"}],"wp:attachment":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/media?parent=4051"}],"wp:term":[{"taxonomy":"accreditation","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/accreditation?post=4051"},{"taxonomy":"speakers","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/speakers?post=4051"},{"taxonomy":"session-themes","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/session-themes?post=4051"},{"taxonomy":"sessions","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions?post=4051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}